期刊文献+

复方黄连滴耳液治疗急性化脓性中耳炎疗效分析 被引量:4

Observation of the efficacy for compound berberine eardrops for acute otitis media
下载PDF
导出
摘要 目的探讨复方黄连滴耳液治疗急性化脓性中耳炎的临床疗效。方法选取2008年7月~2011年8月于笔者所在医院进行治疗的84例(84耳)急性化脓性中耳炎患者为研究对象,将其随机分为A组(氯霉素滴耳液组)42例(42耳)和B组(复方黄连滴耳液组)42例(42耳),将两组患者的总有效率、显效时间、细菌清除率、听力改善幅度、不良反应发生率及患者满意率进行统计及比较。结果 B组治疗总有效率、细菌清除率及满意率均高于A组,显效时间短于A组,听力改善幅度大于A组,不良反应发生率低于A组,差异均有统计学意义(P<0.05)。结论复方黄连滴耳液治疗急性化脓性中耳炎的临床疗效较好,安全性也较好。 Objective To investigate the clinical efficacy for compound berberine eardrops for acute otitis media. Methods 84 cases (84 ears) with acute otitis media patients in the hospital for treatment from July 2008 to August 2011 were chosen as the research object.They were randomly divided into group A (chloramphenicol eardrops group) with 42 patients (42 ears) and group B (compound berberine ear drops group)with 42 cases (42 ears).The total efficiency, effective time, bacterial eradication rate, hearing improvement rate, and incidence of adverse reactions and patients' satisfaction rate for the patients of the two groups were taken for statistics and comparison. Results The total effective bacterial clearance rate and satisfaction rate in B group were higher than group A, marked time was shorter than the A group, hearing improvement was greater than the group A, lower incidence of adverse reactions was lower than group A,there was a significant difference (P 〈 0.05). Conclusion The clinical efficacy of compound coptis eardrops for acute otitis media have a better effect and safety.
作者 古志浩
出处 《中国医药科学》 2012年第3期105-106,共2页 China Medicine And Pharmacy
关键词 复方黄连滴耳液 急性化脓性中耳炎 临床疗效 Compound berberine ear drops Acute otitis media Clinical efficacy
  • 相关文献

参考文献5

二级参考文献24

  • 1张璞玉,赵金霞,司心玲,赵会元,孙波,刘蓬蓬.慢性化脓性中耳炎病人细菌感染分析[J].齐鲁医学杂志,2006,21(2):140-141. 被引量:2
  • 2王玉芝,吴玉梅,张宗珍,翟付敏,田临红,项秀云.慢性化脓性中耳炎病原菌及耐药性分析[J].中国耳鼻咽喉头颈外科,2006,13(6):403-405. 被引量:24
  • 3HawkeyPM. Mechanismsof quinolone action and microbial response [ J] Antimicrob Chemo - ther,2003,51:29.
  • 4BaBB, ArpinC, VidaillacC, et al. Activity of gatifloxacin in an in vitro pharmacokinetie- pharmacodynamic model agaist staphylococcus aureus strains either susceptible tociprofloxaein or exhibiting varlons lev- els and mechanism of jprofloxacin resistance [ J]. Antimicrob AgentsChemother,2006,50 ( 6 ) : 1931.
  • 5Wang T, TanakaM, Sato K. Detction of grlA and gyrA mutations in 344 staphylococcus anreus strains [ J ] . Antimicrob Agents Chemother , 1998,42(2) :236 -240.
  • 6Fournier B, Hooper D. Mutations in topoisomerase IV and DNA gy- rase of staphlococcus aureus : novel pleiotropic effects on quinolone and coumarin activity [ J ]. Antimcrob Agents Chemother, 1998,42 (1) :121 -128.
  • 7Tanaka M, Onodera Y, Uchicla Y, et al. Quinolone resistance muta- tions in the GrlBprotein of staphylococcus aureus [ J]. Antimicreb A- gents Chemother, 1998,42( 11 ) :3044.
  • 8Sehmitz FJ, Jones ME, Homfann B, et al. Charaetemitiong of grlA, grlB,gyrA and gyrB mutations in 116 unrelated isolates of staphylococcus aureus and effects of mutations on ciprofloxacin MIC [ J ] ~ Antimicrob Agents Chemother, 1998,42 (5) : 1249 - 1252.
  • 9Kukeishi A, Diver JM, Beckthold B ,et al, Cloning and nucleotide seqience of P. aeruginosa gyrA gene from PA01 and quinolone - resistant clinical isolates [ J ]. Antimicrob Agents Chemother, 1994,38 ( 9 ) : 1994 - 1952.
  • 10Yonezawa M, Takahata M, Matsubara N, etal. DNA gyase gyrA muta- tions in quinolone - resistant clinical isolates of Psudomonas aeruginosa[ J]. Antimicrob Agents Chemother,1995,39(9) :1970 -1972.

共引文献8

同被引文献33

引证文献4

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部